In this article we report initial experiments applying nonequilibrium atmospheric pressure, pulsed, floating electrode dielectric barrier discharge in ophthalmology. We show that plasma can be applied to the eye both ex vivo in explanted pig eyes and in vivo in live rabbits and pigs. The results show effective sterilization below the threshold of significant damage to the cornea. This research is in the initial stages but is instrumental in the understanding of plasma's ability to become a novel therapeutic tool in ophthalmology.
I. INTRODUCTION
Celebrating over a decade of research, the field of Plasma Medicine continues to grow rapidly. [1] [2] [3] [4] [5] [6] [7] There are a increasing number of medical applications, including, for example, the development of antimicrobial coatings using both high-and low-pressure plasma discharges [8] [9] [10] [11] [12] ; plasma treatment and preparation of medical textiles and fibers [13] [14] [15] ; plasma-assisted stimulation of plant cell growth, seed germination, and other agriculture-related applications 4, [16] [17] [18] [19] [20] [21] [22] ; direct plasma decontamination of foodstuffs [23] [24] [25] [26] ; and the many medically relevant therapeutic treatment ideas such as plasma treatment of cancers, 1,27-42 treatment of inflammatory bowel disease, 43 skin treatment (primarily for sterilization), [44] [45] [46] and blood coagulation, [47] [48] [49] [50] [51] as well as many others. There even have been initial attempts at explaining the complex biochemical and biological mechanisms of nonequilibrium discharge interaction with living systems. 49, [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] The focus of this work is the interaction of nonequilibrium atmospheric pressure dielectric barrier discharge (DBD) with the surface and cells of the eye. There are important challenges in ophthalmology that plasmas may be able to address. The key challenges we are investigating are capillary coagulation during eye surgery, 64 sterilization of corneal tissue, which is an important challenge in many eye surgeries and drug injections, and treating uveal melanomas using plasmas. [65] [66] [67] [68] [69] The conjunctiva, the thin, moist, transparent membrane covering the surface of the eye, serves as the primary protection of the ocular surface; it contains many capillary blood vessels that, under normal conditions, are barely visible. The conjunctival blood vessels are somewhat fragile and can easily break, especially during surgical intervention with a scalpel or a needle used for drug injection. [70] [71] [72] [73] Subconjunctival hemorrhage can easily be prevented with plasma-assisted capillary coagulation. 43, 47, 48, 50, 51, 74 Of course, the conjunctiva serves as a barrier against pathogenic organisms entering the eye. [75] [76] [77] Once the barrier is broken, plasma treatment may be used to inactivate pathogenic organisms on the surface of the eye to prevent infection. In this article we present effective sterilization of the eye both ex vivo with explanted pig eyes and in vivo in rabbits and pigs. We observe some level of damage at higher plasma doses, but there is clearly a dose where no visible damage to the eye is observed while effective and fast sterilization is achieved. Finally, we discuss some of the initials steps taken toward treatment of deep-tissue ailments of the eye, with an example of uveal melanoma treatment.
II. MATERIALS AND METHODS

A. Floating Electrode DBD
The floating electrode DBD (FE-DBD) plasma was constructed as we have described
FIG. 1:
Schematic of the plasma treatment probe on the surface of the eye: A) surface of the eye; B) plasma between the electrode and the eye; C) hard contact lens to mimic curvature of the eye; D) plastic electrode housing; E) high voltage metal electrode; and F) silver paste to provide good contact between the curved contact lens C) and the metal electrode E) previously. 51, 78, 79 Simply, plasma is generated by the application of short pulses of ~2-μsec duration and ~30-kV amplitude to a quartz-covered metal electrode (Fig. 1 ). This way, plasma is generated between the surface being treated and the electrode. It is important to note that the living tissue, in this case tissue of the eye in a live animal, is used as a second active electrode and participates in the plasma generation. All the active species generated in plasma, such as hydrogen peroxide (H 2 O 2 ), OH, and O 3 , charges, and light comes in direct contact with the tissue being treated. Many groups previously showed that this is an effective antimicrobial treatment. 3, 27, [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] To visualize the FE-DBD plasma treatment, we used an electrode we designed for ocular treatment and, as a second electrode, borosilicate glass coated with indium tin oxide (ITO) (Fisher Scientific). Figure 2 shows the setup with ITO-coated glass on the left and the eye treatment electrode on the right. In this case the voltage is turned off and plasma is visible. When the discharge is turned on while keeping the room lights on, the discharge is barely visible, as can be seen in Fig. 3 .
The reader is urged to note the apparent uniformity of the discharge; of course, this pulsed plasma is nonuniform on the microscopic time and surface scales but to the eye appears quite uniform. In fact, in the dark the discharge can been seen through ITO-coated glass (see Fig. 4 ) and a fairly uniform treatment over the 1-second exposure time (the shutter is kept open for 1 second to accumulate sufficient light) can be observed. Since most treatments are on multisecond time scales, we can assume that most of the surface receives a uniform dose of plasma; however, this still remains an open question that needs to be answered in further studies.
B. Plasma Treatment of Agarose Gel
Agarose gels were prepared using agar powder (Fisher Scientific) and distilled water according to standard procedures. The agar powder and water solution was boiled on a hot plate until clear. While the solution was boiling, the stock solutions from the H 2 O 2 / horseradish peroxidase (HRP) assay kit were prepared according to the protocol provided by Life Technologies. 
1X Reaction Buffer
Add 4 mL of 5X Reaction Buffer (component C, white cap) to 16 mL of deionized water. This 20-mL volume of 1X reaction buffer working solution is sufficient for approximately 100 assays (100 μL each) with 10 mL excess for making stock solutions.
HRP Stock Solution (10 U/mL)
Dissolve the contents of the vial of HRP (component D, yellow cap) in 1.0 mL of 1X reaction buffer. After the assay, divide any unused HRP stock solution into single-use aliquots and store frozen at -20°C. After the agar solution became clear, the contents were cooled to 60°C. The stock solutions from the Amplex Red H 2 O 2 /HRP kit were combined and added to the cooling agar solution and mixed thoroughly. Five milliliters of the solution was added to culture plates and cooled until solidified. Once the plates were cooled to room temperature, they were treated with FE-DBD plasma for 5, 10, and 15 seconds. Areas of plasma discharge were seen as pink spots. The diameters of these spots were marked and measured. Figure 5 shows a schematic of the animal treatment protocol for live eye sterilization. For our treatments we administer a 100-µL drop of bacteria in phosphatebuffered saline onto the cornea (Figs. 5 and 6 ), attempting to keep the drop in the center while holding the animal. The plasma treatment is applied exactly as described above for a predetermined amount of time. After the treatment, we collect bacteria on a sterile cotton swab and then roll this swab over the surface of blood agar (Cardinal Health). Bacteria then are incubated at 37°C for 24 hours, after which the colony-forming units 
H 2 O 2 Working Solution (20 mM)
C. Plasma Treatment of the Eye
III. RESULTS AND DISCUSSION
A. Analysis of Plasma Treatment of Agarose Gel
We prepared agarose gel as described above and treated it with plasma the same way we later treated the eyes and as described above. Figure 7 shows a photograph of the agarose gel following 3 seconds of plasma treatment. The pinkish color of the dye clearly shows the area that received the treatment. Figure 8 shows rather expected results: We observed an increase in the diameter of active species in the gel with increasing plasma treatment dose. Similar results were reported previously (by Dirks et al., 25 for example) and we now frequently use this technique to validate the presence of reactive species in the treatment area. The size of the electrode (Fig. 2) is just less than 3 mm (copper part); however, the plasma extends beyond that, as can be seen from Figs. 3 and 4. Thus the spread of reactive species in agarose to >5 mm after just a few seconds of treatment is not unreasonable. While this is not the subject of this article, we plan to investigate in the future mechanisms of reactive species penetration through gels and tissues, focusing especially on the type of species. 
B. Plasma Sterilization of Explanted Pig Cornea
FIG. 8:
Results of plasma discharge diameter test for treatment times of 3s, 5s, and 7s
FIG. 9:
Schematic of the plasma treatment of eye (same basic setup was used for both explanted eyes and live animals): A) explanted eye in a grounded petri dish (B) or the animal eye; C) high voltage pulsed power supply; D) eye treatment electrode as shown in Figure 1 ; E) Z-micropositioner (used with explanted eyes); and F) plasma generated between the powered electrode and the surface of the cornea experiments reported here. Basically, the typical quartz-coveted copper electrode is connected to a microsecond-pulsed, high-voltage power supply through an ~1-m-long cable. The electrode itself is held by hand approximately 2 mm away from the surface. This is clearly not a precise technique and is heavily reliant on the operator, like many similar surgical techniques. We do plan to address this with a redesign of the probe, similar to the schematic presented in Fig. 5 . The surgeon applying the treatment did not report having trouble maintaining a reasonably similar treatment distance of ~2 mm for all treatments. Figure 10 visually explains the treatment protocol we used for the explanted pig Scrape eyes, purchased from a local butcher. First, we clean the eyes as best as we can in an attempt to minimize damage to the cornea. Then we soak the eyes in 70% isopropanol for 2 minutes to remove any existing bacteria. We follow this with rinsing and air-drying for 15 minutes under a fume hood, then we deposit a 100-µL drop of bacteria and, finally, perform plasma treatment followed by immediate swab and culture on blood agar. Figure 11 shows a set of photographs of the explanted pig eyes after plasma treatment. The photos are taken usually within a minute following treatment, not exceeding 3 minutes for any of them. As can be seen, there is no visible effect on the cornea that can be observed by a camera. There is, however, slight drying that can be observed and that we noticed later in the rabbit and pig eyes. In the future we plan to perform histopathological analysis of the treated samples.
As can be seen in Fig. 12 , we are able to achieve highly effective bacterial inactivation on the surface of the explanted eye. While this comes as no surprise-similar inactivation rates have previously been reported 51, 96, 97 -the reader will notice that these inactivation rates are significantly higher than what we report below for the in vivo treatments. We do not understand the mechanisms of such a notable difference in effect and plan to investigate this further in the future. Notably, a similar issue was observed in plasma-assisted sterilization of wounds in live animals; the bacterial reduction rated on in vivo wounds and other biological surfaces was much less than that on the model agarose gel surface. 25, 45, 51, 57, 96, 98 
C. Plasma Sterilization of Live Rabbit Cornea
Similar to the schematic in Fig. 9, Fig. 13 shows a typical procedure in which the animal is held steady by the veterinarian and the plasma is applied by the surgeon. Figure 14 shows results of plasma treatment of live rabbit cornea and inactivation of Staphylococcus aureus on the surface. From the initial concentration of ~10 6 colo- ny-forming units/mL, we quickly reduced the bacterial load by ~2 logs; further reduction requires a slightly higher dose. Figure 15 shows the procedure for treatment of live pig cornea and Fig. 16 is a zoomed-
D. Plasma Sterilization of Live Pig Cornea
Staphylococcus aureus log10 (CFUs)
in view of the procedure. While one of the surgeons keeps the animal's eye open with tweezers, the second surgeon applies the plasma. Clearly, the treatment methodology needs to be optimized in the future: a few plasma filaments can be seen (Fig. 16 ) to jump to the metal tweezers. The surgeons, however, reported being quite comfortable using the probe and keeping the appropriate distance from the eye as they were instructed. Figure 17 shows the eye once it was swabbed for bacterial counts and removed for analysis. As is quite apparent from Fig. 18 , which is a zoomed-in view of Fig. 17 , there is significant drying of the cornea following the 30-second plasma treatment. Figure 19 shows a different animal (pig 3) being treated with plasma by a single surgeon. The operator is able to hold the eye open and perform the treatment comfortably. Similar to Fig. 17 , in Figs. 21 and 22 we observe drying of the corneal surface following the 30-second plasma treatment. We did observe significantly less drying with the 15-second treatment (not shown), which leads us to believe that the effect is dose-dependent and can thus be optimized. We did this previously with treatment of mouse skin; we were able to achieve as much as 45 minutes of treatment without tissue damage. 51 While the 15-second treatment led to less tissue drying, we did not observe significant sterilization (Fig. 23 ). We were able to achieve reduction of ~2 logs with the 30-second treatment regime. Based on our experience with treatment of live surfaces, we may attribute such low inactivation (compared with the results on agarose gel 51 or on explanted eyes reported above) to the treatment and collection procedure. As we noted, we apply a 100-µL drop to the surface of the cornea, which is already wet because the animal is alive. The drop quickly spreads over the eye. While we treat a ~5-mm circle with plasma (see agarose gel data above), the surface over which bacteria is spread and is collected from is much larger. We plan to modify the treatment, collection, and analysis protocol in the future to address this complication.
IV. CONCLUSION
In this article we show that treatment of a live animal cornea is possible with FE-DBD plasma without excessive damage to the cornea. Moreover, we show that this treatment leads to effective reduction of pathogenic bacteria on the surface of the cornea. Bacteria here are used as a model for the treatment of live animal eyes. The key challenge is treating eye diseases, and this article presents our first step in this direction. Clearly, many unanswered questions must be resolved before plasma treatment of the eye becomes a medical product. As can be clearly observed (in Fig. 18, for example) , there is apparent damage to the animal eye from higher doses of plasma. While this damage is not significant enough to break the delicate surface of the cornea, the animal is likely to suffer at least some level of discomfort. There is also an observed drying of the corneal surface (which can be addressed by adding saline, for example).
